← Leaderboards
Shelia Brockette Dunaway
University Of Washington
$506,296
Attributed
$506,296
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $332.5K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$506,296 · 2
By mechanism
M01$506,296 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Ann Cornwall Collier$29,777,747
- Evan D Kharasch$17,406,013
- Kris Kowdley$16,222,064
- Lisa M Frenkel$29,105,317
- Edward A Clark$26,060,534
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsAffectAids Clinical Trial GroupAids TherapyBloodChemokine ReceptorClinical ResearchClinical Trial Phase IComputer Retrieval Of Information On Scientific Projects DatabaseCxcr4 GeneDosageDoseDrug Adverse EffectDrug KineticsDrug Screening /EvaluationElectrocardiogramEnrollmentEvaluationFoodFundingGrantHeartHiv InfectionsHuman Subject
Grant awards (4)
A PHASE I, DOSE-RISING STUDY OF AMD11070 IN HIV-SERONEGATIVE MEN, A5191$3,680
M01 · FY2007 · RR · contact PI
A PHASE I, DOSE-RISING STUDY OF AMD11070 IN HIV-SERONEGATIVE MEN, A5191$332,538
M01 · FY2006 · RR · contact PI
A PHASE I, DOSE-RISING STUDY: AMD11070 IN HIV-SERONEGATIVE MEN, A5191$77,302
M01 · FY2005 · RR
PHASE I, DOSE-RISING STUDY OF AMD11070 IN HIV-SERONEG$92,776
M01 · FY2004 · RR